SCHEMBL18398362

SCHEMBL18398362

COc1ccc(C(=O)Nc2nc(NCc3c(F)cc(C#N)cc3CC(F)F)cc3c2ncn3C)c(OC)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR6 P46095 4/20 0.37
▸ JAK2 O60674 2/20 0.35
▸ JAK1 P23458 2/20 0.35
▸ TYK2 P29597 2/20 0.35
▸ JAK3 P52333 2/20 0.35
▸ CFTR P13569 1/20 0.35
▸ TP53 P04637 4/20 0.34
▸ NPC1 O15118 4/20 0.34
▸ RAB9A P51151 4/20 0.34
▸ MITF O75030 1/20 0.34
▸ GAA P10253 1/20 0.34
▸ AURKA O14965 1/20 0.34
▸ RPS6KB1 P23443 1/20 0.34
▸ AURKB Q96GD4 1/20 0.34
▸ ALDH1A1 P00352 2/20 0.33
▸ LMNA P02545 2/20 0.33
▸ RXFP1 Q9HBX9 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18398203 0.90 GPR6 (0.37) GPR6JAK2JAK1TYK2JAK3
SCHEMBL18398365 0.87 CYP1A2 (0.42) TP53NPC1RAB9AGAAALDH1A1
SCHEMBL18398424 0.85 GPR6 (0.39) GPR6CFTRTP53NPC1RAB9A
SCHEMBL18398361 0.84 JAK2 (0.40) GPR6JAK2JAK1TYK2JAK3
SCHEMBL18398511 0.82 CYP1A2 (0.43) JAK2JAK1TYK2JAK3TP53
SCHEMBL18398299 0.80 PDE4A (0.38) GPR6CFTRTP53NPC1RAB9A
SCHEMBL18398297 0.80 GPR6 (0.37) GPR6JAK2JAK1TYK2JAK3
SCHEMBL18398471 0.79 JAK2 (0.52) GPR6JAK2JAK1TYK2JAK3
SCHEMBL18398298 0.79 CYP1A2 (0.46) TP53NPC1RAB9AGAAALDH1A1
SCHEMBL18398204 0.78 CYP1A2 (0.40) TP53NPC1RAB9AGAARPS6KB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017012647-A1 NOVEL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2017-01-26 — — WO disclosed
Send feedback